An immunology fellow at Brigham and Women’s Hospital provided perspective on the positive impacts a new diagnostic criterion for MOGAD brings to the clinical community. [WATCH TIME: 4 minutes]
Anastasia Vishnevetsky, MD
Advertisement
Articles by Anastasia Vishnevetsky, MD
The immunology fellow at Brigham and Women’s Hospital discussed the current state of care for patients with MOGAD, and whether treatment decisions differ based on timing of attacks. [WATCH TIME: 7 minutes]
Advertisement
Latest Updated Articles
Significance of New MOGAD Diagnosis Criteria, Inclusion of MOG-IgG: Anastasia Vishnevetsky, MDPublished: April 19th 2023 | Updated:
Timing of Treatment and Managing Attacks in MOGAD: Anastasia Vishnevetsky, MDPublished: April 10th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Exploring the Role of Aerobic Exercise in Promoting Remyelination in Multiple Sclerosis: Lindsey Wooliscroft, MD, MS
2
NLRP3 Inhibitor VTX3232 Well Tolerated, Improves Parkinson Symptoms in Phase 2a Trial
3
Episode 152: Building Safer, Smarter, and More Personalized Epilepsy Care
4
OnabotulinumtoxinA Meets Primary End Point in Phase 2 ELATE Trial for Upper Limb Essential Tremor
5
